Accendra Health (ACH) Gross Margin (2009 - 2026)
Accendra Health (ACH) posted quarterly Gross Margin of 44.29% for Q1 2026, down 3377.0% year-over-year from 1.35% in Q1 2025, and down 2.87% quarter-over-quarter from 45.6% in Q4 2025.
Accendra Health (ACH) Gross Margin (2009 - 2026) Analysis & Trends
Accendra Health (ACH) has reported Gross Margin for 18 consecutive years, with 44.29% the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Margin fell 3377.0% year-over-year to 44.29%; the TTM figure through Mar 2026 stood at 47.35% (down 3401.0% YoY), while the FY2025 annual figure was 46.68%, down 3612.0% from the prior year.
- Gross Margin slipped to 44.29% in Q1 2026 per ACH's latest filing, from 45.6% in the prior quarter.
- Across five years, Gross Margin topped out at 83.42% in Q4 2024 and bottomed at 11.12% in Q4 2023.
- Historically, Gross Margin has averaged 38.71% across 5 years, with a median of 21.3% in 2022.
- Annual changes were most pronounced in 2024 — Gross Margin jumped 9454 bps — and 2025, when it tumbled 3782 bps.
- Accendra Health's Gross Margin stood at 15.96% in 2022, then plunged by 170 bps to 11.12% in 2023, then soared by 850 bps to 83.42% in 2024, then plunged by 45 bps to 45.6% in 2025, then dropped by 3 bps to 44.29% in 2026.
- Business Quant data shows ACH's Gross Margin at 44.29% in Q1 2026, 45.6% in Q4 2025, and 46.21% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 101.82 Bn | 96.65 Bn | 3.69 Bn | 3.50% |
| 2 | Cencora | 61.46 Bn | 58.65 Bn | 3.61 Bn | 4.26% |
| 3 | Cardinal Health | 54.37 Bn | 49.52 Bn | 2.56 Bn | 4.02% |
| 4 | Henry Schein | 10.03 Bn | 9.87 Bn | 1.10 Bn | 31.84% |
| 5 | Akso Health | 820.26 Mn | 820.04 Mn | - | - |
| 6 | Edap Tms | 157.62 Mn | 136.08 Mn | 7.34 Mn | 55.58% |
| 7 | Accendra Health | 97.02 Mn | 89.37 Mn | 263.41 Mn | 42.95% |
| 8 | 111 | 30.87 Mn | 109.39 Mn | 18.18 Mn | 5.31% |
| 9 | Cosmos Health | 13.12 Mn | 10.67 Mn | 1.51 Mn | 7.96% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 14.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42.95% |
| Mar 31, 2026 | 44.29% |
| Dec 31, 2025 | 45.60% |
| Sep 30, 2025 | 46.21% |
| Jun 30, 2025 | 53.14% |
| Mar 31, 2025 | 78.06% |
| Dec 31, 2024 | 83.42% |
| Sep 30, 2024 | 81.49% |
| Jun 30, 2024 | 82.40% |
| Mar 31, 2024 | 20.50% |
| Dec 31, 2023 | -11.12% |
| Sep 30, 2023 | 20.78% |
| Jun 30, 2023 | 20.26% |
| Mar 31, 2023 | 19.71% |
| Dec 31, 2022 | 15.96% |
| Sep 30, 2022 | 20.55% |
| Jun 30, 2022 | 21.30% |
| Mar 31, 2022 | 15.52% |
| Dec 31, 2021 | 13.84% |
| Sep 30, 2021 | 13.14% |